Ann: Appendix 4D and Half Year Accounts, page-9

Harrvet

https://ipowatch.com.au/2016-ipo-performance/

So currently, a 520% gain from inception just over a year and a half ago. I earn a six figure salary. Over the course of 2017, my portfolio in NOX comfortably exceeded that figure.

And I don't mean to sound braggadocios. I would bet that other holders have done better - quite considerably perhaps given I fit the bill of a simple "Mum and Dad' investor.

Now since Dr Garner assumed the role of Novogen CEO, that company's share price is in fact still in the red. And he's had what around two years to do something about that.

So on that account, where should the disquiet, frustration or criticism truly lie? With NOX or NRT/KZA shareholders?

And if anyone employs an outrageous level of polly speak - {or in other words bull#$&t}, I think the evidence points directly to you.